TickerFacts.

Celldex Therapeutics, Inc. (CLDX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$28.87M
As of 2025-12-31
$47.45M
As of 2026-06-30
-0.6%
3-year compound annual growth
-8.0%
5-year compound annual growth
-8.7%
10-year compound annual growth
$169.40M2009-12-31: $57.00M2010-12-31: $21.29M2011-12-31: $11.90M2012-12-31: $24.90M2013-12-31: $169.40M2014-12-31: $28.02M2015-12-31: $72.11M2016-12-31: $42.46M2017-12-31: $40.29M2018-12-31: $24.31M2019-12-31: $11.23M2020-12-31: $43.84M2021-12-31: $39.14M2022-12-31: $29.43M2023-12-31: $34.81M2024-12-31: $28.36M2025-12-31: $28.87M$28.87M
2009-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$28.87M+1.8%2026-02-25, Balance as of period end
2024-12-31$28.36M-18.6%2026-02-25, Balance as of period end
2023-12-31$34.81M+18.3%2025-02-27, Balance as of period end
2022-12-31$29.43M-24.8%2024-02-26, Balance as of period end
2021-12-31$39.14M-10.7%2023-02-28, Balance as of period end
2020-12-31$43.84M+290.3%2022-02-28, Balance as of period end
2019-12-31$11.23M-53.8%2021-03-29, Balance as of period end
2018-12-31$24.31M-39.7%2021-03-29, Balance as of period end
2017-12-31$40.29M-5.1%2020-03-26, Balance as of period end
2016-12-31$42.46M-41.1%2019-03-07, Balance as of period end
2015-12-31$72.11M+157.3%2018-03-07, Balance as of period end
2014-12-31$28.02M-83.5%2017-03-14, Balance as of period end
2013-12-31$169.40M+580.4%2016-02-25, Balance as of period end
2012-12-31$24.90M+109.2%2015-02-24, Balance as of period end
2011-12-31$11.90M-44.1%2014-03-03, Balance as of period end
2010-12-31$21.29M-62.7%2013-03-08, Balance as of period end
2009-12-31$57.00Mn/a2012-03-08, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%

Compare CLDX, VNRX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗